Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian Ai

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Cancer Research|April 5, 2005
Targeting tomoregulin for radioimmunotherapy of prostate cancerXiao-Yan Zhao, Doug Schneider, Sandra L Biroc, et al.
Cancer Research|April 6, 2006
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in cultureJian-Ai Xuan, Doug Schneider, Pam Toy, et al.
Cancer Research|September 17, 2005
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancerRenate Parry, Doug Schneider, Debra Hudson, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Cancer Research|April 5, 2005
Targeting tomoregulin for radioimmunotherapy of prostate cancerXiao-Yan Zhao, Doug Schneider, Sandra L Biroc, et al.
Cancer Research|April 6, 2006
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in cultureJian-Ai Xuan, Doug Schneider, Pam Toy, et al.
Cancer Research|September 17, 2005
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancerRenate Parry, Doug Schneider, Debra Hudson, et al.
Pageof 4